146 related articles for article (PubMed ID: 16729897)
21. Regulation of IAPs gene family by interleukin-1 alpha and Epstein-Barr virus in nasopharyngeal carcinoma.
Chua HH; Yeh TH; Wang YP; Sheen TS; Shew JY; Huang YT; Tsai CH
Head Neck; 2008 Dec; 30(12):1575-85. PubMed ID: 18798303
[TBL] [Abstract][Full Text] [Related]
22. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
23. Expression of Etk/Bmx tyrosine kinase in the tumorigenicity of nasopharyngeal epithelium and its relation with EB virus infection and the apoptosis-related protein Bcl-2.
Guo L; Guo Y; Xiao S
Cancer Lett; 2006 Feb; 232(2):255-61. PubMed ID: 16458122
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
Liu JP; Cassar L; Pinto A; Li H
Cell Res; 2006 Oct; 16(10):809-17. PubMed ID: 17016469
[TBL] [Abstract][Full Text] [Related]
26. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
27. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of Epstein-Barr virus A73 gene polymorphisms to susceptibility to nasopharyngeal carcinoma].
Zhang LL; Li DJ; Li ZH; Zhang XS; Zhang RH; Yu XJ; Chen LZ; Feng QS; Zeng YX; Jia WH
Ai Zheng; 2007 Oct; 26(10):1047-51. PubMed ID: 17927871
[TBL] [Abstract][Full Text] [Related]
29. [Expression of DeltaNp63 protein in nasopharyngeal carcinoma and its significance].
Liao ZL; Deng ZL; Zhang B; Xie KS
Ai Zheng; 2004 Mar; 23(3):288-91. PubMed ID: 15025959
[TBL] [Abstract][Full Text] [Related]
30. The Primary Study on Expression and Function of D-Type Cyclins in Nasopharyngeal Carcinoma Cell Lines.
Zhao XR; Gu HH; Weng XX; Yi W; Deng XY; Cao Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(2):192-196. PubMed ID: 12098801
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
[TBL] [Abstract][Full Text] [Related]
33. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
Zhou Y; Zeng Z; Zhang W; Xiong W; Li X; Zhang B; Yi W; Xiao L; Wu M; Shen S; Li X; Cao L; Tang K; Li G
Eur J Cancer Prev; 2008 Nov; 17(6):561-71. PubMed ID: 18941378
[TBL] [Abstract][Full Text] [Related]
34. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
35. Role of the RARRES1 gene in nasopharyngeal carcinoma.
Kwok WK; Pang JC; Lo KW; Ng HK
Cancer Genet Cytogenet; 2009 Oct; 194(1):58-64. PubMed ID: 19737656
[TBL] [Abstract][Full Text] [Related]
36. Purification of novel UBAP1 protein and its decreased expression on nasopharyngeal carcinoma tissue microarray.
Xiao B; Fan S; Zeng Z; Xiong W; Cao L; Yang Y; Li W; Wang R; Tang K; Qian J; Shen S; Li X; Li G
Protein Expr Purif; 2006 May; 47(1):60-7. PubMed ID: 16226037
[TBL] [Abstract][Full Text] [Related]
37. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx.
Liu ZQ; Tian YQ; Hu YF; Li XL; Ma FR; Li GY
Chin Med J (Engl); 2009 Feb; 122(4):437-43. PubMed ID: 19302751
[TBL] [Abstract][Full Text] [Related]
38. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
[TBL] [Abstract][Full Text] [Related]
39. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM
Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485
[TBL] [Abstract][Full Text] [Related]
40. [Mining gene expression microarray data of nasopharyngeal carcinoma by literature profiling].
Huang ZX; Yao KT
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):798-801. PubMed ID: 15257907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
